Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN (CSP) AND ANTISENSE CSP

  • Read more about CELLULAR APOPTOSIS SUSCEPTIBILITY PROTEIN (CSP) AND ANTISENSE CSP
US Patent 6,156,564
Filed on 1997-12-05

METHODS FOR SEQUENCING LARGE NUCLEIC ACID SEGMENTS AND COMPOSITIONS FOR LARGE SEQUENCING PROJECTS

  • Read more about METHODS FOR SEQUENCING LARGE NUCLEIC ACID SEGMENTS AND COMPOSITIONS FOR LARGE SEQUENCING PROJECTS
Patent Cooperation Treaty
PCT/US1997/008114
Filed on 1997-05-14

An Anti-Cyanovirin Antibody

  • Read more about An Anti-Cyanovirin Antibody
US Patent 5,998,587
Filed on 1997-11-13

Antiviral Proteins, DNA Coding Sequences Therefor, and Uses Thereof

  • Read more about Antiviral Proteins, DNA Coding Sequences Therefor, and Uses Thereof
US Patent 6,987,096
Filed on 1997-11-13

TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS

  • Read more about TISSUE-SPECIFIC TREATMENT, DIAGNOSTIC METHODS, AND COMPOSITIONS USING REPLICATION-DEFICIENT VECTORS
US Application 08/849,120
Filed on 1997-05-28

Nucleic Acids Encoding Antiviral Proteins and Peptides Fused to Effector Proteins

  • Read more about Nucleic Acids Encoding Antiviral Proteins and Peptides Fused to Effector Proteins
US Patent 5,962,668
Filed on 1997-11-13

Methods Of Using Cyanovirins

  • Read more about Methods Of Using Cyanovirins
US Patent 6,015,876
Filed on 1997-11-13

Methods Of Obtaining Antiviral Proteins And Antiviral Peptides From Nostoc Ellipsosporum

  • Read more about Methods Of Obtaining Antiviral Proteins And Antiviral Peptides From Nostoc Ellipsosporum
US Patent 5,962,653
Filed on 1997-11-13

AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY

  • Read more about AUTOTAXIN: MOTILITY STIMULATING PROTEIN USEFUL IN CANCER DIAGNOSIS AND THERAPY
US Patent 6,084,069
Filed on 1997-11-24

SELECTIVE PREVENTION OF ORGAN INJURY IN SEPSIS AND SHOCK USING SELECTION RELEASE OF NITRIC OXIDE IN VULNERABLE ORGANS

  • Read more about SELECTIVE PREVENTION OF ORGAN INJURY IN SEPSIS AND SHOCK USING SELECTION RELEASE OF NITRIC OXIDE IN VULNERABLE ORGANS
US Patent 5,814,656
Filed on 1997-10-02

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1539
  • Page 1540
  • Page 1541
  • Page 1542
  • Page 1543
  • Page 1544
  • Page 1545
  • Page 1546
  • Page 1547
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health